Product NDC: | 0591-4012 |
Proprietary Name: | Valproic |
Non Proprietary Name: | Valproic Acid |
Active Ingredient(s): | 250 mg/1 & nbsp; Valproic Acid |
Administration Route(s): | ORAL |
Dosage Form(s): | CAPSULE, LIQUID FILLED |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0591-4012 |
Labeler Name: | Watson Laboratories, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA073229 |
Marketing Category: | ANDA |
Start Marketing Date: | 20090908 |
Package NDC: | 0591-4012-01 |
Package Description: | 100 CAPSULE, LIQUID FILLED in 1 BOTTLE (0591-4012-01) |
NDC Code | 0591-4012-01 |
Proprietary Name | Valproic |
Package Description | 100 CAPSULE, LIQUID FILLED in 1 BOTTLE (0591-4012-01) |
Product NDC | 0591-4012 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Valproic Acid |
Dosage Form Name | CAPSULE, LIQUID FILLED |
Route Name | ORAL |
Start Marketing Date | 20090908 |
Marketing Category Name | ANDA |
Labeler Name | Watson Laboratories, Inc. |
Substance Name | VALPROIC ACID |
Strength Number | 250 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE],Mood Stabilizer [EPC] |